Titans of Pharma 2018: An Infographic Snapshot Of The Industry's Top Leaders
Executive Summary
In 2017, the top 15 pharma companies paid their CEOs a total of $251m in salary and other benefits, while reporting net income of $56.5bn. But while income was down 41% on 2016, compensation declined by a more modest 9%. In this infographic, Scrip provides a snapshot of these companies' leaders and the businesses they oversee.
You may also be interested in...
Titans Of Pharma – A Snapshot Of The Industry's Top Leaders, An Infographic
In 2016, the 15 top pharma companies paid their CEOs $276m in total* while those same firms reported a total net income of $96.5bn**. Altogether these companies had a market capitalization of $2,238bn on June 30, 2017**. In this infographic Scrip gives a snapshot of these companies' leaders and the businesses they oversee.
Top-Selling Drugs 2023: Pharma’s $60bn COVID-19 Cliff
Pfizer/BioNTech’s COVID-19 vaccine Comirnaty toppled after recording the highest ever annual sales for a pharmaceutical in 2022, while Novo Nordisk’s Ozempic climbed rapidly. But Merck & Co’s immuno-oncology blockbuster Keytruda was secure in the number one spot in 2023 as COVID-19 receded.
20 Voices: What Does 2024 Hold For Biopharma?
20 executives in the biopharma industry outline their view of key trends this year. A selection of commentary from a broad industry survey by Scrip.